UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Analysis of entities with the lowest risk in crypto, plus how to interpret liquidity, use case maturity, and developer activity for safer bets.
28,397 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Oil prices slide to the low $70s as Middle East risk cools, fueling debates on whether the Federal Reserve has paused...
Investors are tracing a familiar 1990 Gulf War playbook as oil climbs and energy shares outperform, while the broader...
The michael burry bear case returns to the AI chip story as depreciation gaps collide with decade-long financing, thr...
A major family-office investor has increased its position in Middleby as the company prepares a spin-off. This move o...
Oil futures climbed after the U.S. Treasury canceled a license that allowed limited Iranian oil sales, triggering a f...
In a volatile market, three names stand out for reliable income: Realty Income, EPR Properties, and Verizon. Each del...
A senior strategist has a bold projection for the S&P 500, arguing the index could reach 8,500 by end-2027 as a geopo...
Remaining defendants in the Roberts sexual assault lawsuit have filed motions to dismiss, pushing back against claims...
NVIDIA’s push beyond chips is drawing investor attention to life sciences. This article breaks down what Jensen Huang...
Pricing conversations in real estate have moved from fixed numbers to dynamic narratives driven by financing, data, a...
Palantir Technologies stock popped today on an earnings-tease event, not a full report. This article explains the dri...